Cargando…

The 2023 Bethesda system for reporting thyroid cytopathology: novi sub sole, subdivision is no more debatable, in thyroidology

Detalles Bibliográficos
Autores principales: Sengul, Ilker, Sengul, Demet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Médica Brasileira 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645164/
https://www.ncbi.nlm.nih.gov/pubmed/37971139
http://dx.doi.org/10.1590/1806-9282.20231124
_version_ 1785147326722998272
author Sengul, Ilker
Sengul, Demet
author_facet Sengul, Ilker
Sengul, Demet
author_sort Sengul, Ilker
collection PubMed
description
format Online
Article
Text
id pubmed-10645164
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Associação Médica Brasileira
record_format MEDLINE/PubMed
spelling pubmed-106451642023-11-13 The 2023 Bethesda system for reporting thyroid cytopathology: novi sub sole, subdivision is no more debatable, in thyroidology Sengul, Ilker Sengul, Demet Rev Assoc Med Bras (1992) Commentary Associação Médica Brasileira 2023-11-13 /pmc/articles/PMC10645164/ /pubmed/37971139 http://dx.doi.org/10.1590/1806-9282.20231124 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Sengul, Ilker
Sengul, Demet
The 2023 Bethesda system for reporting thyroid cytopathology: novi sub sole, subdivision is no more debatable, in thyroidology
title The 2023 Bethesda system for reporting thyroid cytopathology: novi sub sole, subdivision is no more debatable, in thyroidology
title_full The 2023 Bethesda system for reporting thyroid cytopathology: novi sub sole, subdivision is no more debatable, in thyroidology
title_fullStr The 2023 Bethesda system for reporting thyroid cytopathology: novi sub sole, subdivision is no more debatable, in thyroidology
title_full_unstemmed The 2023 Bethesda system for reporting thyroid cytopathology: novi sub sole, subdivision is no more debatable, in thyroidology
title_short The 2023 Bethesda system for reporting thyroid cytopathology: novi sub sole, subdivision is no more debatable, in thyroidology
title_sort 2023 bethesda system for reporting thyroid cytopathology: novi sub sole, subdivision is no more debatable, in thyroidology
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645164/
https://www.ncbi.nlm.nih.gov/pubmed/37971139
http://dx.doi.org/10.1590/1806-9282.20231124
work_keys_str_mv AT sengulilker the2023bethesdasystemforreportingthyroidcytopathologynovisubsolesubdivisionisnomoredebatableinthyroidology
AT senguldemet the2023bethesdasystemforreportingthyroidcytopathologynovisubsolesubdivisionisnomoredebatableinthyroidology
AT sengulilker 2023bethesdasystemforreportingthyroidcytopathologynovisubsolesubdivisionisnomoredebatableinthyroidology
AT senguldemet 2023bethesdasystemforreportingthyroidcytopathologynovisubsolesubdivisionisnomoredebatableinthyroidology